These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 36382274)
21. Bridge-Clamp Bis(tetrazine)s with [N] Mboyi CD; Vivier D; Daher A; Fleurat-Lessard P; Cattey H; Devillers CH; Bernhard C; Denat F; Roger J; Hierso JC Angew Chem Int Ed Engl; 2020 Jan; 59(3):1149-1154. PubMed ID: 31643125 [TBL] [Abstract][Full Text] [Related]
22. Clickable modular polysaccharide nanoparticles for selective cell-targeting. Peuler K; Dimmitt N; Lin CC Carbohydr Polym; 2020 Apr; 234():115901. PubMed ID: 32070522 [TBL] [Abstract][Full Text] [Related]
23. Development of a bioorthogonal and highly efficient conjugation method for quantum dots using tetrazine-norbornene cycloaddition. Han HS; Devaraj NK; Lee J; Hilderbrand SA; Weissleder R; Bawendi MG J Am Chem Soc; 2010 Jun; 132(23):7838-9. PubMed ID: 20481508 [TBL] [Abstract][Full Text] [Related]
24. Inverse electron-demand diels-alder reactions of tetrazine and norbornene at the air-water interface. Nakahara H; Hagimori M; Kannaka K; Mukai T; Shibata O Colloids Surf B Biointerfaces; 2022 Mar; 211():112333. PubMed ID: 35038654 [TBL] [Abstract][Full Text] [Related]
25. Homodimeric Protein-Polymer Conjugates via the Tetrazine- Lorenzo MM; Decker CG; Kahveci MU; Paluck SJ; Maynard HD Macromolecules; 2016 Jan; 49(1):30-37. PubMed ID: 26949271 [TBL] [Abstract][Full Text] [Related]
26. Advances in CRISPR-Cas systems for RNA targeting, tracking and editing. Wang F; Wang L; Zou X; Duan S; Li Z; Deng Z; Luo J; Lee SY; Chen S Biotechnol Adv; 2019; 37(5):708-729. PubMed ID: 30926472 [TBL] [Abstract][Full Text] [Related]
27. Applications of the CRISPR-Cas9 system in kidney research. Higashijima Y; Hirano S; Nangaku M; Nureki O Kidney Int; 2017 Aug; 92(2):324-335. PubMed ID: 28433382 [TBL] [Abstract][Full Text] [Related]
28. Tetrazine-based cycloadditions: application to pretargeted live cell imaging. Devaraj NK; Weissleder R; Hilderbrand SA Bioconjug Chem; 2008 Dec; 19(12):2297-9. PubMed ID: 19053305 [TBL] [Abstract][Full Text] [Related]
29. Exploiting the tetrazine-norbornene reaction for single polymer chain collapse. Hansell CF; Lu A; Patterson JP; O'Reilly RK Nanoscale; 2014 Apr; 6(8):4102-7. PubMed ID: 24604159 [TBL] [Abstract][Full Text] [Related]
32. Two-Step Activity-Based Protein Profiling with the Proteasome System as Model of Study. Soriano GP; Overkleeft HS; Florea BI Methods Mol Biol; 2017; 1491():205-215. PubMed ID: 27778291 [TBL] [Abstract][Full Text] [Related]
33. CRISPR/Cas genome editing to optimize pharmacologically active plant natural products. Dey A Pharmacol Res; 2021 Feb; 164():105359. PubMed ID: 33285226 [TBL] [Abstract][Full Text] [Related]
34. Applications of the versatile CRISPR-Cas13 RNA targeting system. Kordyś M; Sen R; Warkocki Z Wiley Interdiscip Rev RNA; 2022 May; 13(3):e1694. PubMed ID: 34553495 [TBL] [Abstract][Full Text] [Related]
36. Expanding room for tetrazine ligations in the in vivo chemistry toolbox. Sečkutė J; Devaraj NK Curr Opin Chem Biol; 2013 Oct; 17(5):761-7. PubMed ID: 24021760 [TBL] [Abstract][Full Text] [Related]
38. Harnessing the native type I-B CRISPR-Cas for genome editing in a polyploid archaeon. Cheng F; Gong L; Zhao D; Yang H; Zhou J; Li M; Xiang H J Genet Genomics; 2017 Nov; 44(11):541-548. PubMed ID: 29169919 [TBL] [Abstract][Full Text] [Related]
39. Design of SaCas9-HF for In Vivo Gene Therapy. Tiwari K; Kumar R; Saudagar P Methods Mol Biol; 2023; 2575():261-268. PubMed ID: 36301479 [TBL] [Abstract][Full Text] [Related]
40. Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Esvelt KM; Mali P; Braff JL; Moosburner M; Yaung SJ; Church GM Nat Methods; 2013 Nov; 10(11):1116-21. PubMed ID: 24076762 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]